Hu, Q., Zuo, X., Gu, X., Liu, L., Tang, Y., Niu, X., Shi, Y., Han, L. (2025). CXCL8 is essential for cervical cancer cell acquired radioresistance and acts as a promising therapeutic target in cervical cancer. Scientific Reports. https://doi.org/10.1038/s41598-025-05435-w